ASCO GU Symposium announces new findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
The latest analysis, presented Feb. 13-14 at the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2025), further solidifies the effectiveness of the lenvatinib (Lenvima) and pembrolizumab (Keytruda) combination in treating this aggressive form of kidney cancer. Hutson played a key role in the study and provided insights into the impact of these findings.
"This analysis reinforces that greater tumor shrinkage correlates with improved survival outcomes," Hutson said. "We now have compelling evidence that reducing overall tumor burden not only extends survival but also enhances the effectiveness of subsequent treatments, setting patients up for better long-term prognoses."
The study, which initially led to the FDA approval of lenvatinib plus pembrolizumab for advanced renal cell carcinoma in 2021, continues to provide valuable insights into treatment strategies. The new findings demonstrate that patients with greater reductions in total tumor size at disease progression had significantly longer median survival rates. Additionally, data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) show that patients receiving the combination therapy were more likely to maintain or improve their IMDC risk scores, further supporting the regimen's impact on long-term survival.
"These findings emphasize the importance of aggressive tumor reduction in the fight against renal cell carcinoma," Hutson added. "The data suggest that this combination therapy offers the best outcomes among currently available treatments, making it a strong contender for first-line treatment in advanced renal cell carcinoma."
TTUHSC and UMC Health System remain committed to advancing cancer treatment and improving patient outcomes through innovative research and clinical excellence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto
TORONTO, July 25, 2025 /CNW/ - From July 27 to 31, Toronto hosts the Alzheimer's Association International Conference® 2025 (AAIC®), the world's largest forum for dementia research. With Canada in the spotlight, Baycrest is recognized globally for its leadership in aging and brain health. Our scientists and experts are participating in the conference and available to support your coverage. This international gathering offers a timely opportunity to explore the growing impact of dementia on families, economies and health care systems, along with the latest advances in prevention, care, treatment and research. Dr. Howard ChertkowScientific Director, Baycrest's Kimel Family Centre for Brain Health & WellnessScientific Director, Canadian Consortium on Neurodegeneration in Aging (CCNA)Dr. Chertkow is a member of the AAIC Scientific Program Committee and one of Canada's most respected dementia researchers. He is available to speak on topics including dementia detection, prevention, treatment and Canada's role in the global research landscape. More Baycrest Experts You Can Speak With Dr. Adriana Shnall, Program Director, Baycrest Koschitzky Centre for Innovations in Caregiving, can speak to innovative tools supporting dementia caregivers, including those in rural and underserved communities. At AAIC, she is co-presenting on the use of virtual reality, AI and other strategies to better support families in community and long-term care settings. Dr. Allison Sekuler, President & Chief Scientist, Baycrest Academy for Research and Education is available to speak on the rising prevalence of dementia in Canada and its impact on individuals, families and the healthcare system. Dr. Nicole Anderson, Associate Scientific Director, Baycrest's Kimel Family Centre for Brain Health & Wellness, can discuss the latest in dementia prevention research, including evidence that nearly half of all cases may be preventable. Baycrest combines world-class care with cutting-edge research to help shape the future of aging and brain health. If you are working on AAIC-related coverage or broader dementia stories, our experts are available for interviews throughout the conference. Throughout the week, we will share updates with media highlighting key topics, research developments and expert perspectives from Baycrest. Please contact Natasha Nacevski-Laird, Media Relations Specialist at Baycrest, to schedule an interview. About Baycrest At Baycrest, our vision is a world where every older person lives with purpose, fulfilment and dignity. Baycrest is a global leader in aging and brain health innovation, with over 105 years of expertise in seniors' care and cutting-edge research. Baycrest has been Designated with Exemplary Status by Accreditation Canada, and drives industry-leading care and safety outcomes. As the home of the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, the Baycrest Academy for Research and Education (BARE) and the Canadian Consortium on Neurodegeneration in Aging, Baycrest is at the forefront of dementia research. Affiliated with the University of Toronto, Baycrest's training programs shape the future of care globally, while Baycrest Global Solutions extends its expertise to senior living and healthcare internationally. For more information, visit: SOURCE Baycrest View original content to download multimedia:
Business Upturn
3 days ago
- Business Upturn
CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — CLEAR (NYSE: YOU), the secure identity platform, is participating in the Centers for Medicare & Medicaid Services (CMS) Health Tech Ecosystem initiative, a nationwide effort to deliver a more connected, patient-centered healthcare system. CLEAR was proud to stand alongside government, healthcare, and technology leaders at the White House this week to support the launch of this national collaboration, and to reinforce its role as the trusted, full service Identity Assurance Level 2 (IAL2)/Authenticator Assurance Level 2 (AAL2) identity layer underpinning partner ecosystems across healthcare. 'CLEAR applauds the Administration's commitment to accelerating the digital transformation of healthcare and is proud to be a trusted partner in this nationwide effort,' said Caryn Seidman Becker, CEO of CLEAR. 'By serving as an IAL2 identity layer in healthcare ecosystems, CLEAR is helping to kill the clipboard, eliminate friction, and give patients control of their medical information in a secure, seamless way. We believe identity is the key to unlocking personalized, efficient, and patient-centered care.' At the heart of this CMS-led effort is a push to make health data more accessible, interoperable, and actionable, empowering patients, reducing provider burden, and improving outcomes. CLEAR's reusable identity platform for healthcare organizations and businesses, CLEAR1, is already enabling this transformation across leading platforms and health systems, including Epic, Surescripts, Wellstar, Community Health Network, University of Miami Health and These partners are leveraging CLEAR1 for use cases such as streamlining patient onboarding and check-in, enhancing workforce security, simplifying access to medical records, and strengthening data protection. Together, these efforts demonstrate how secure, interoperable identity can reduce friction, lower costs, and enable a more connected healthcare experience. CLEAR1 is a NIST IAL2/AAL2-compliant identity solution that gives patients and providers a reusable, privacy-centric credential to unlock services across the care journey, whether creating a MyChart account, verifying coverage, or accessing claims data. Over 60 companies have signed on to the CMS Health Tech Ecosystem pledge, committing to advance tools that: Help patients manage chronic conditions like diabetes and obesity Use AI assistants to navigate symptoms and schedule care 'Kill the clipboard' by digitizing check-in and intake Securely share data across trusted networks using modern identity credentials 'We are excited that identity services – like CLEAR – are making it possible for patients and providers to use verified, secure identity as part of CMS's Health Tech Ecosystem,' said Amy Gleason, Acting Administrator for the U.S. DOGE Service and Strategic Advisor to the Department of Health and Human Services and the Centers for Medicare and Medicaid. 'Checking in at the doctor's office should be the same as boarding a flight. Patients should be able to scan a QR code to instantly and safely share their identity, insurance and medical history'. 'Our work with CLEAR has meaningfully improved the speed and reliability of provider identity verification across our network,' said Frank Harvey, CEO of Surescripts. 'It's a powerful example of how focused collaboration can drive real progress. This pledge builds on that momentum—demonstrating how innovators across healthcare are advancing interoperability to reduce administrative burden and refocus clinicians' time where it matters most: patient care.' 'Identity is foundational to creating the connected, consumer-first healthcare experience that people expect, and it's what was built to deliver,' said Kristen Valdes, CEO and Founder of 'Our partnership with CLEAR brings a trusted, IAL2-compliant identity layer into that experience, giving patients and caregivers a seamless, unified way to access and share their health information across providers and platforms.' 'As part of our pledge to become a CMS Aligned Network, our relationship and planned integration with CLEAR will give us a unique opportunity to bring IAL2 identity verification to providers who are newer to the interoperability space,' said Therasa Bell, President and Founder of Kno2. 'That includes nurses, physical therapists, behavioral health providers, dentists, and paramedics, and it will enable them to securely communicate and share patient records across the broader healthcare ecosystem.' 'Modern identity is the key to enabling safe, secure, and trusted data exchange across healthcare,' said Aneesh Chopra, former Chief Technology Officer of the United States. 'CLEAR's work to deliver IAL2-compliant digital identity helps unlock the promise of interoperability—giving patients and providers the confidence to share information seamlessly and securely.' CLEAR1 is already powering many of these functions across CLEAR's health, financial services, and workforce partners—and stands ready to support the rollout of CMS-Aligned Networks in 2026 and beyond. About CLEAR CLEAR's mission is to strengthen security and create frictionless experiences. With over 31 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you – making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we never sell Member data. For more information, visit . Forward-Looking Statements This release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements relating to CLEAR's participation in the CMS Health Tech Ecosystem initiative. Investors are cautioned that any and such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the initiative and CLEAR's participation therein, and those described in the Company's filings within the Securities and Exchange Commission, including the sections titled 'Risk Factors' in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein. CLEAR [email protected] This press release was published by a CLEAR® Verified individual. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
3 days ago
- Yahoo
CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem
As the IAL2 identity layer for major healthcare partners, CLEAR supports CMS's nationwide initiative to modernize care through trusted, interoperable technologies NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity platform, is participating in the Centers for Medicare & Medicaid Services (CMS) Health Tech Ecosystem initiative, a nationwide effort to deliver a more connected, patient-centered healthcare system. CLEAR was proud to stand alongside government, healthcare, and technology leaders at the White House this week to support the launch of this national collaboration, and to reinforce its role as the trusted, full service Identity Assurance Level 2 (IAL2)/Authenticator Assurance Level 2 (AAL2) identity layer underpinning partner ecosystems across healthcare. 'CLEAR applauds the Administration's commitment to accelerating the digital transformation of healthcare and is proud to be a trusted partner in this nationwide effort,' said Caryn Seidman Becker, CEO of CLEAR. 'By serving as an IAL2 identity layer in healthcare ecosystems, CLEAR is helping to kill the clipboard, eliminate friction, and give patients control of their medical information in a secure, seamless way. We believe identity is the key to unlocking personalized, efficient, and patient-centered care.' At the heart of this CMS-led effort is a push to make health data more accessible, interoperable, and actionable, empowering patients, reducing provider burden, and improving outcomes. CLEAR's reusable identity platform for healthcare organizations and businesses, CLEAR1, is already enabling this transformation across leading platforms and health systems, including Epic, Surescripts, Wellstar, Community Health Network, University of Miami Health and These partners are leveraging CLEAR1 for use cases such as streamlining patient onboarding and check-in, enhancing workforce security, simplifying access to medical records, and strengthening data protection. Together, these efforts demonstrate how secure, interoperable identity can reduce friction, lower costs, and enable a more connected healthcare experience. CLEAR1 is a NIST IAL2/AAL2-compliant identity solution that gives patients and providers a reusable, privacy-centric credential to unlock services across the care journey, whether creating a MyChart account, verifying coverage, or accessing claims data. Over 60 companies have signed on to the CMS Health Tech Ecosystem pledge, committing to advance tools that: Help patients manage chronic conditions like diabetes and obesity Use AI assistants to navigate symptoms and schedule care 'Kill the clipboard' by digitizing check-in and intake Securely share data across trusted networks using modern identity credentials "We are excited that identity services - like CLEAR - are making it possible for patients and providers to use verified, secure identity as part of CMS's Health Tech Ecosystem," said Amy Gleason, Acting Administrator for the U.S. DOGE Service and Strategic Advisor to the Department of Health and Human Services and the Centers for Medicare and Medicaid. "Checking in at the doctor's office should be the same as boarding a flight. Patients should be able to scan a QR code to instantly and safely share their identity, insurance and medical history". 'Our work with CLEAR has meaningfully improved the speed and reliability of provider identity verification across our network,' said Frank Harvey, CEO of Surescripts. 'It's a powerful example of how focused collaboration can drive real progress. This pledge builds on that momentum—demonstrating how innovators across healthcare are advancing interoperability to reduce administrative burden and refocus clinicians' time where it matters most: patient care.' 'Identity is foundational to creating the connected, consumer-first healthcare experience that people expect, and it's what was built to deliver,' said Kristen Valdes, CEO and Founder of 'Our partnership with CLEAR brings a trusted, IAL2-compliant identity layer into that experience, giving patients and caregivers a seamless, unified way to access and share their health information across providers and platforms.' 'As part of our pledge to become a CMS Aligned Network, our relationship and planned integration with CLEAR will give us a unique opportunity to bring IAL2 identity verification to providers who are newer to the interoperability space,' said Therasa Bell, President and Founder of Kno2. 'That includes nurses, physical therapists, behavioral health providers, dentists, and paramedics, and it will enable them to securely communicate and share patient records across the broader healthcare ecosystem." 'Modern identity is the key to enabling safe, secure, and trusted data exchange across healthcare,' said Aneesh Chopra, former Chief Technology Officer of the United States. 'CLEAR's work to deliver IAL2-compliant digital identity helps unlock the promise of interoperability—giving patients and providers the confidence to share information seamlessly and securely.' CLEAR1 is already powering many of these functions across CLEAR's health, financial services, and workforce partners—and stands ready to support the rollout of CMS-Aligned Networks in 2026 and beyond. About CLEARCLEAR's mission is to strengthen security and create frictionless experiences. With over 31 million Members and a growing network of partners across the world, CLEAR's secure identity platform is transforming the way people live, work, and travel. Whether you are traveling, at the stadium, or on your phone, CLEAR connects you to the things that make you, you – making everyday experiences easier, more secure, and friction-free. CLEAR is committed to privacy done right. Members are always in control of their own information, and we never sell Member data. For more information, visit Forward-Looking StatementsThis release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This includes, without limitation, statements relating to CLEAR's participation in the CMS Health Tech Ecosystem initiative. Investors are cautioned that any and such forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties, and that actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the initiative and CLEAR's participation therein, and those described in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein. CLEARmedia@ This press release was published by a CLEAR® Verified in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
